RG
RDY icon

Renaissance Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Renaissance Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-632,460
Closed -$8.27M – 281
2021
Q4 		$8.27M Sell
632,460
-76,395
-11% -$963K 0.34% 88
2021
Q3 		$9.23M Sell
708,855
-54,655
-7% -$728K 0.4% 82
2021
Q2 		$11.2M Sell
763,510
-52,895
-6% -$740K 0.47% 65
2021
Q1 		$10M Sell
816,405
-31,370
-4% -$403K 0.42% 94
2020
Q4 		$12.1M Sell
847,775
-46,345
-5% -$624K 0.52% 66
2020
Q3 		$12.4M Sell
894,120
-132,245
-13% -$1.58M 0.58% 57
2020
Q2 		$10.9M Sell
1,026,365
-117,585
-10% -$1.2M 0.52% 69
2020
Q1 		$9.23M Buy
+1,143,950
New +$9.54M 0.51% 84

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Group's RDY Position: Q1 2022 in Review

Renaissance Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2022, closing a stake of 632,460 shares — an estimated $8.27M sold.

Renaissance Group first reported a position in RDY in Q1 2020 and held it in 8 quarters. The position peaked at $12.4M in Q3 2020. 145 funds tracked by Wall St. Rank hold RDY as of Q1 2022.

  • Renaissance Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2022 after selling out during the quarter.
  • Renaissance Group sold 632,460 Dr. Reddy's Laboratories shares in Q1 2022, an estimated $8.27M.
  • Renaissance Group first reported a position in Dr. Reddy's Laboratories in Q1 2020 and held it in 8 quarters.
  • Renaissance Group's Dr. Reddy's Laboratories position peaked at $12.4M in Q3 2020.
  • 145 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2022.

Based on Renaissance Group's 13F filing for Q1 2022, filed 13 May 2022.